Skip to content

RAAP Advocacy Highlight

Changes in Medicare Part D Benefit Design Can Impact Availability of Future Treatments

With almost 50 million beneficiaries enrolled in the program, the Medicare prescription drug benefit
(Part D) is considered by many to be a model of a successful government insurance program.
Beneficiary premiums have declined 13.5% over the past 5 years, and most regions of the country
have many prescription drug plan options for beneficiaries.

...Read More

  • Who We Are
  • Initiatives
  • Resources
  • Events
  • Media
  • Contact
  • Quorum
© copyright 2021 RARE ACCESS ACTION PROJECT | Privacy Policy